Internal Iliac Artery Ligation and Abnormally Invasive Placenta

This trial is set to detect the impact of bilateral internal iliac artery ligation on the amount of intra-operative blood loss during the hysterectomy procedure done for the management of abnormally invasive placenta

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Placenta Percreta Female Urogenital Diseases and Pregnancy Complications Obstetric Labor Complications Placenta Accreta Placenta Diseases Pregnancy Complications Urogenital Diseases

Age range

20 year–45 year

Sex eligibility

Female

Study type

Interventional

Phase

Not applicable

Primary location

Kasr el aini hospital

Cairo, Cairo Governorate, 12211, Egypt

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

females with pre-operative diagnosis of abnormally invasive placenta

Exclusion criteria

refusal to get enrolled in the study

Treatment and study plan

internal iliac artery ligation

Procedure

Cesarean Hysterectomy

Procedure

Primary outcomes

amount of intra-operative hemorrhage

Time frame: 2-3 hours

Sponsors and collaborators

Lead sponsor

Cairo University

Other

Registry information

Important dates

Study start: 2016
Primary completion: 2017
Study completion: 2017
First posted: Apr 5, 2016
Registry last updated: Apr 18, 2017

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed